phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington's disease clinical trial REGEN4HD

* Huntington's disease is a genetic disorder that gradually destroys brain cells over the course of 10 to 30 years, typically starting between the ages of 35 and 50 * Phase 1b/2a will evaluate the safety of the treatment and provides hope for those with few options to slow the progression of the disease * Clinical trial will enroll 21 people with early-stage Huntington's disease, with 12 participants in a phase 1b dose-escalation group and nine in a phase 2a expansion group

June 23, 2026


June 26 2026

June 25 2026

June 24 2026

June 23 2026

June 22 2026

June 21 2026

June 19 2026

June 18 2026

June 17 2026

June 16 2026

June 15 2026

June 14 2026

June 13 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy